Core Insights - The strategic partnership between Ark Health and Fosun Pharma aims to enhance chronic disease management, particularly focusing on psoriasis through AI technology [1][2] - The collaboration will leverage both companies' strengths to create a comprehensive management system for psoriasis patients, addressing existing challenges in traditional management methods [2][4] Group 1: Strategic Collaboration - Ark Health and Fosun Pharma signed a strategic cooperation agreement to work closely in the "AI + Chronic Disease Management" sector, focusing on autoimmune diseases like psoriasis [1] - The partnership will involve deep academic collaboration, digital marketing, and the application of AI technology to improve disease awareness, intervention, and long-term management [1][2] Group 2: AI Integration in Disease Management - The collaboration will utilize Ark Health's AI health manager to provide personalized rehabilitation recommendations and continuous tracking for psoriasis patients [2] - An AI medication assistant will offer 24/7 medication consultation, ensuring scientific and safe management of psoriasis [2] Group 3: Public Awareness and Education - The "AI + New Perspectives on Psoriasis Management" public awareness week was launched, utilizing AI technology to enhance health education efficiency and quality [2][4] - The initiative aims to transform health education from a one-way communication model to a user-centered, data-driven, and sustainable interaction approach [4] Group 4: Future Prospects - The partnership is expected to expand beyond psoriasis management to cover a broader range of chronic diseases, contributing to the development of a robust health management ecosystem in China [4] - Ark Health's strategic vision includes the acceleration of its "AI +" ecosystem blueprint, with plans to implement similar innovative models in other chronic disease management areas [4]